Commerzbank Aktiengesellschaft Myriad Genetics Inc Transaction History

Commerzbank Aktiengesellschaft

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 17, 2020	SELL	$20.93 - $35.1 $418,600 - $702,000	-20,000 Closed	0 $0
Q3 2019 Oct 03, 2024	BUY	$22.08 - $47.08 $441,599 - $941,600	20,000 New	20,000 $573,000
Q2 2019 Oct 03, 2024	BUY	$22.67 - $35.0 $453,400 - $700,000	20,000 New	20,000 $556,000
Q1 2019 Oct 03, 2024	BUY	$26.93 - $34.7 $538,600 - $694,000	20,000 New	20,000 $664,000
Q4 2018 Oct 03, 2024	BUY	$27.23 - $45.56 $544,600 - $911,200	20,000 New	20,000 $581,000
Q3 2018 Oct 04, 2024	BUY	$37.57 - $50.34 $751,400 - $1.01 Million	20,000 New	20,000 $920,000
Q2 2018 Oct 04, 2024	BUY	$27.75 - $40.17 $555,000 - $803,400	20,000 New	20,000 $747,000
Q4 2017 Oct 04, 2024	BUY	$28.45 - $37.14 $569,000 - $742,800	20,000 New	20,000 $687,000
Q2 2017 Aug 09, 2017	BUY	N/A	20,000	20,000 $517,000

238

92.7M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.77B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.